Abstract:Abstract Background Disease-drug associations provide essential information for drug discovery and disease treatment. Many disease-drug associations remain unobserved or unknown, and trials to confirm these associations are time-consuming and expensive. To better understand and explore these valuable associations, it would be useful to develop computational methods for predicting unobserved disease-drug associations. With the advent of various datasets describing diseases and drugs, it has become more feasible to build a model describing the potential correlation between disease and drugs. Results In this work, we propose a new prediction method, called LMFDA, which works in several stages. First, it studies the drug chemical structure, disease MeSH descriptors, disease-related phenotypic terms, and drug-drug interactions. On this basis, similarity networks of different sources are constructed to enrich the representation of drugs and diseases. Based on the fused disease similarity network and drug similarity network, LMFDA calculated the association score of each pair of diseases and drugs in the database. This method achieves good performance on Fdataset and Cdataset, AUROCs were 91.6% and 92.1% respectively, higher than many of the existing computational models. Conclusions The novelty of LMFDA lies in the introduction of multimodal fusion using low-rank tensors to fuse multiple similar networks and combine matrix complement technology to predict potential association. We have demonstrated that LMFDA can display excellent network integration ability for accurate disease-drug association inferring and achieve substantial improvement over the advanced approach. Overall, experimental results on two real-world networks dataset demonstrate that LMFDA able to delivers an excellent detecting performance. Results also suggest that perfecting similar networks with as much domain knowledge as possible is a promising direction for drug repositioning.

Predicting Drug-Disease Associations via Meta-path Representation Learning based on Heterogeneous Information Net works

Multi-level Subgraph Representation Learning for Drug-Disease Association Prediction over Heterogeneous Biological Information Network.

RLFDDA: a meta-path based graph representation learning model for drug–disease association prediction

NEDD: a Network Embedding Based Method for Predicting Drug-Disease Associations

Drug-disease association prediction using semantic graph and function similarity representation learning over heterogeneous information networks

An effective drug-disease associations prediction model based on graphic representation learning over multi-biomolecular network

MRLDTI: A Meta-path-Based Representation Learning Model for Drug-Target Interaction Prediction

An Explainable Framework for Predicting Drug-Side Effect Associations Via Meta-Path-Based Feature Learning in Heterogeneous Information Network.

HINGRL: predicting drug–disease associations with graph representation learning on heterogeneous information networks

Predicting Drug-Disease Associations Through Similarity Network Fusion and Multi-View Feature Projection Representation.

Learning from low-rank multimodal representations for predicting disease-drug associations

Association Mining to Identify Microbe Drug Interactions Based on Heterogeneous Network Embedding Representation

Predicting Circrna-Disease Associations Using Meta Path-Based Representation Learning on Heterogenous Network.

Drug-Disease Association Prediction Based on Neighborhood Information Aggregation in Neural Networks

HNet-DNN: Inferring New Drug-Disease Associations with Deep Neural Network Based on Heterogeneous Network Features.

Meta-Path Based Mirna-Disease Association Prediction

TLNPMD: Prediction of miRNA-Disease Associations Based on miRNA-Drug-Disease Three-Layer Heterogeneous Network

Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning

LDAH2V: Exploring Meta-Paths Across Multiple Networks for lncRNA-Disease Association Prediction

Prediction of drug–disease associations based on reinforcement symmetric metric learning and graph convolution network

Deep Multiple Instance Learning on Heterogeneous Graph for Drug-Disease Association Prediction.